We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$16.4B
AUM Growth
-$2.15B
Cap. Flow
-$2.61B
Cap. Flow %
-15.88%
Top 10 Hldgs %
31.19%
Holding
350
New
12
Increased
112
Reduced
185
Closed
6

Top Buys

Rank Stock Value
1
TRV icon
Travelers Companies
TRV
+$52.8M
2
FAST icon
Fastenal
FAST
+$16.3M
3
USB icon
US Bancorp
USB
+$16.2M
4
ADI icon
Analog Devices
ADI
+$15.6M
5
OTIS icon
Otis Worldwide
OTIS
+$11.7M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$145M
2
TFC icon
Truist Financial
TFC
+$119M
3
TXN icon
Texas Instruments
TXN
+$110M
4
MRK icon
Merck
MRK
+$107M
5
BLK icon
Blackrock
BLK
+$98M

Sector Composition

Rank Sector Weight
1 Technology 21.59%
2 Healthcare 14.65%
3 Financials 12.29%
4 Consumer Staples 12.17%
5 Industrials 12.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSX icon
226
CSX Corp
CSX
$93.1B
$1.46M 0.01%
42,702
-1,347
-3% -$42.6K
AIT icon
227
Applied Industrial Technologies
AIT
$13.3B
$1.45M 0.01%
10,000
MMM icon
228
3M
MMM
$94.3B
$1.3M 0.01%
15,528
-6,115
-28% -$519K
EHC icon
229
Encompass Health
EHC
$12.4B
$1.27M 0.01%
18,811
-5,665
-23% -$355K
NDSN icon
230
Nordson
NDSN
$17.3B
$1.27M 0.01%
5,128
-175
-3% -$39K
ZBH icon
231
Zimmer Biomet
ZBH
$18.4B
$1.27M 0.01%
8,694
-16
-0.2% -$2.17K
VIGI icon
232
Vanguard International Dividend Appreciation ETF
VIGI
$9.3B
$1.26M 0.01%
16,770
+2,790
+20% +$210K
MCHP icon
233
Microchip Technology
MCHP
$46B
$1.24M 0.01%
13,861
+211
+2% +$16.6K
GILD icon
234
Gilead Sciences
GILD
$165B
$1.21M 0.01%
15,643
+264
+2% +$21.1K
IBM icon
235
IBM
IBM
$224B
$1.18M 0.01%
8,814
+1,498
+20% +$193K
POOL icon
236
Pool Corp
POOL
$7.5B
$1.18M 0.01%
3,146
+30
+1% +$10.3K
CAT icon
237
Caterpillar
CAT
$387B
$1.16M 0.01%
4,714
+95
+2% +$21.2K
FR icon
238
First Industrial Realty Trust
FR
$8.44B
$1.11M 0.01%
+21,125
New +$1.1M
WST icon
239
West Pharmaceutical
WST
$24.9B
$1.07M 0.01%
2,810
-237
-8% -$84.7K
CVS icon
240
CVS Health
CVS
$122B
$1.06M 0.01%
15,319
-3,302
-18% -$235K
SHW icon
241
Sherwin-Williams
SHW
$89.8B
$1.05M 0.01%
3,962
-29
-0.7% -$6.83K
STZ icon
242
Constellation Brands
STZ
$23.2B
$1.05M 0.01%
4,268
-247
-5% -$57.8K
LW icon
243
Lamb Weston
LW
$7.19B
$1.04M 0.01%
9,020
+147
+2% +$16.4K
IEMG icon
244
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$1.01M 0.01%
20,538
+96
+0.5% +$4.69K
HI
245
DELISTED
Hillenbrand
HI
$998K 0.01%
19,460
DE icon
246
Deere & Co
DE
$168B
$977K 0.01%
2,410
+75
+3% +$28.7K
TSLA icon
247
Tesla
TSLA
$1.3T
$969K 0.01%
3,701
-3
-0.1% -$600
STAG icon
248
STAG Industrial
STAG
$7.19B
$929K 0.01%
25,903
+12,376
+91% +$428K
MCO icon
249
Moody's
MCO
$82.7B
$894K 0.01%
2,570
-188
-7% -$59.6K
NEM icon
250
Newmont
NEM
$119B
$860K 0.01%
20,170
+899
+5% +$40.8K

Similar funds

Bahl & Gaynor's Q2 2023 Portfolio in Review

As of Q2 2023, Bahl & Gaynor held 350 positions worth $16.4B, down 12% from $18.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor withdrew a net $2.61B in Q2 2023, closing 6 positions and reducing 185 holdings. Its most notable exit was Advance Auto Parts, an estimated $6.13M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Bahl & Gaynor opened a new position in Conagra Brands worth $8.05M.

  • Bahl & Gaynor's largest Q2 2023 buy was Conagra Brands: 238,703 shares worth $8.05M.
  • Bahl & Gaynor added most to Travelers Companies in Q2 2023, an estimated $52.8M increase.
  • Bahl & Gaynor's biggest Q2 2023 reduction was Broadcom, cutting an estimated $145M.
  • Bahl & Gaynor fully exited Advance Auto Parts in Q2 2023, selling an estimated $6.13M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $16.4B portfolio in Q2 2023.
  • Bahl & Gaynor opened 12 new positions and closed 6 in Q2 2023.
  • Bahl & Gaynor's portfolio value fell 12% quarter-over-quarter to $16.4B.

Based on Bahl & Gaynor's 13F filing for Q2 2023, filed 14 Aug 2023.